These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 23917959)

  • 1. The generation of induced pluripotent stem cells from a patient with KCNH2 G603D, without LQT2 disease associated symptom.
    Okata S; Yuasa S; Yamane T; Furukawa T; Fukuda K
    J Med Dent Sci; 2013 Mar; 60(1):17-22. PubMed ID: 23917959
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Model for long QT syndrome type 2 using human iPS cells demonstrates arrhythmogenic characteristics in cell culture.
    Lahti AL; Kujala VJ; Chapman H; Koivisto AP; Pekkanen-Mattila M; Kerkelä E; Hyttinen J; Kontula K; Swan H; Conklin BR; Yamanaka S; Silvennoinen O; Aalto-Setälä K
    Dis Model Mech; 2012 Mar; 5(2):220-30. PubMed ID: 22052944
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promise and Potential Peril With Lumacaftor for the Trafficking Defective Type 2 Long-QT Syndrome-Causative Variants, p.G604S, p.N633S, and p.R685P, Using Patient-Specific Re-Engineered Cardiomyocytes.
    O'Hare BJ; John Kim CS; Hamrick SK; Ye D; Tester DJ; Ackerman MJ
    Circ Genom Precis Med; 2020 Oct; 13(5):466-475. PubMed ID: 32940533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Isogenic human pluripotent stem cell pairs reveal the role of a KCNH2 mutation in long-QT syndrome.
    Bellin M; Casini S; Davis RP; D'Aniello C; Haas J; Ward-van Oostwaard D; Tertoolen LG; Jung CB; Elliott DA; Welling A; Laugwitz KL; Moretti A; Mummery CL
    EMBO J; 2013 Dec; 32(24):3161-75. PubMed ID: 24213244
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Generation of human induced pluripotent stem cell line from a patient with a long QT syndrome type 2.
    Fatima A; Ivanyuk D; Herms S; Heilmann-Heimbach S; O'Shea O; Chapman C; Izsvák Z; Farr M; Hescheler J; Šarić T
    Stem Cell Res; 2016 Mar; 16(2):304-7. PubMed ID: 27345990
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KCNH2-K897T is a genetic modifier of latent congenital long-QT syndrome.
    Crotti L; Lundquist AL; Insolia R; Pedrazzini M; Ferrandi C; De Ferrari GM; Vicentini A; Yang P; Roden DM; George AL; Schwartz PJ
    Circulation; 2005 Aug; 112(9):1251-8. PubMed ID: 16116052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
    Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
    J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug evaluation in cardiomyocytes derived from human induced pluripotent stem cells carrying a long QT syndrome type 2 mutation.
    Matsa E; Rajamohan D; Dick E; Young L; Mellor I; Staniforth A; Denning C
    Eur Heart J; 2011 Apr; 32(8):952-62. PubMed ID: 21367833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intragenic suppression of trafficking-defective KCNH2 channels associated with long QT syndrome.
    Delisle BP; Slind JK; Kilby JA; Anderson CL; Anson BD; Balijepalli RC; Tester DJ; Ackerman MJ; Kamp TJ; January CT
    Mol Pharmacol; 2005 Jul; 68(1):233-40. PubMed ID: 15851652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Allele-specific RNA interference rescues the long-QT syndrome phenotype in human-induced pluripotency stem cell cardiomyocytes.
    Matsa E; Dixon JE; Medway C; Georgiou O; Patel MJ; Morgan K; Kemp PJ; Staniforth A; Mellor I; Denning C
    Eur Heart J; 2014 Apr; 35(16):1078-87. PubMed ID: 23470493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Most LQT2 mutations reduce Kv11.1 (hERG) current by a class 2 (trafficking-deficient) mechanism.
    Anderson CL; Delisle BP; Anson BD; Kilby JA; Will ML; Tester DJ; Gong Q; Zhou Z; Ackerman MJ; January CT
    Circulation; 2006 Jan; 113(3):365-73. PubMed ID: 16432067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation and gender-specific risk in type 2 long QT syndrome: implications for risk stratification for life-threatening cardiac events in patients with long QT syndrome.
    Migdalovich D; Moss AJ; Lopes CM; Costa J; Ouellet G; Barsheshet A; McNitt S; Polonsky S; Robinson JL; Zareba W; Ackerman MJ; Benhorin J; Kaufman ES; Platonov PG; Shimizu W; Towbin JA; Vincent GM; Wilde AA; Goldenberg I
    Heart Rhythm; 2011 Oct; 8(10):1537-43. PubMed ID: 21440677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Novel mutations of potassium channel KCNQ1 S145L and KCNH2 Y475C genes in Chinese pedigrees of long QT syndrome].
    Liu WL; Hu DY; Li P; Li CL; Qin XG; Li YT; Li L; Li ZM; Dong W; Qi Y; Wang Q
    Zhonghua Nei Ke Za Zhi; 2006 Jun; 45(6):463-6. PubMed ID: 16831322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Generation of human-induced pluripotent stem cells from gut mesentery-derived cells by ectopic expression of OCT4/SOX2/NANOG.
    Li Y; Zhao H; Lan F; Lee A; Chen L; Lin C; Yao Y; Li L
    Cell Reprogram; 2010 Jun; 12(3):237-47. PubMed ID: 20698766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effect of KCNH2 single nucleotide polymorphism K897T in LQTS families and identification of novel KCNQ1 and KCNH2 mutations.
    Zhang X; Chen S; Zhang L; Liu M; Redfearn S; Bryant RM; Oberti C; Vincent GM; Wang QK
    BMC Med Genet; 2008 Sep; 9():87. PubMed ID: 18808722
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel mutation in the Per-Arnt-Sim domain of KCNH2 causes a malignant form of long-QT syndrome.
    Rossenbacker T; Mubagwa K; Jongbloed RJ; Vereecke J; Devriendt K; Gewillig M; Carmeliet E; Collen D; Heidbüchel H; Carmeliet P
    Circulation; 2005 Mar; 111(8):961-8. PubMed ID: 15699249
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [A novel mutation of the KCNH2 gene in a family with congenital long QT syndrome].
    Lian J; Zhou J; Huang X; Wang Y; Yang X; Li D
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2010 Feb; 27(1):77-80. PubMed ID: 20140874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of three heterozygous KCNH2 mutation-carrying human induced pluripotent stem cell lines for modeling LQT2 syndrome.
    Mondéjar-Parreño G; Jahng JWS; Belbachir N; Wu BC; Zhang X; Perez MV; Badhwar N; Wu JC
    Stem Cell Res; 2021 Jul; 54():102402. PubMed ID: 34051449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Generation and characterization of an induced pluripotent stem cell (iPSC) line (NUIGi003-A) from a long QT syndrome type 2 (LQT2) patient harbouring the KCNH2 c.2464G>A pathogenic variant.
    Ge N; Liu M; Krawczyk J; McInerney V; Ward D; Shen S; O'Brien T; Prendiville T
    Stem Cell Res; 2020 Dec; 49():101997. PubMed ID: 33002718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of patient-specific induced pluripotent stem cell lines with Type 2 Long QT Syndrome and the KCNH2 c.379C > T pathogenic variant.
    Goual L; Bounasri E; Vincenti M; Amédro P; Desprat R; Bernex F; Lemaitre JM; Pasquié JL; Lacampagne A; Thireau J; Meli AC
    Stem Cell Res; 2023 Oct; 72():103192. PubMed ID: 37660555
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.